{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447608674
| IUPAC_name = (3α,14β,16α)-14,15-dihydro-<br>14-hydroxyeburnamenine-14-carboxylic acid methyl ester<br />OR<br />methyl (15''R'',17''S'',19''R'')-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0<sup>2,7</sup>.0<sup>8,18</sup>.0<sup>15,19</sup>]nonadeca-2(7),3,5,8(18)-tetraene-17-carboxylate
| image = Vincamine.svg
| width = 175

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|vincamine}}
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 1617-90-9
| ATC_prefix = C04
| ATC_suffix = AX07
| PubChem = 15376
| IUPHAR_ligand = 349
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1165342 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 996XVD0JHT
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08677
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 14635
|  smiles = O=C(OC)[C@]3(O)n1c4c(c2ccccc12)CCN5CCC[C@](C3)(CC)[C@@H]45
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = RXPRRQLKFXBCSJ-GIVPXCGWSA-N

<!--Chemical data-->
| C=21 | H=26 | N=2 | O=3 
| molecular_weight = 354.44 g/mol
}}

'''Vincamine''' is a monoterpenoid [[indole]] [[alkaloid]] found in the leaves of ''[[Vinca minor]]'' (lesser periwinkle), comprising about 25-65% of the indole alkaloids found in ''Vinca minor'' by weight.  It can be synthesized from related alkaloids.<ref>{{ cite encyclopedia | title = Indole Alkaloids | encyclopedia = Ullmann's Encyclopedia of Industrial Chemistry | edition = Fifth | page = 393 | publisher = Wiley-VCH | year = 1985 | isbn = 3-527-20100-9 }}</ref>

==Biological effects==
Vincamine is a peripheral [[vasodilator]] that increases blood flow to the brain (sold under the trademark '''Oxybral SR''') .

Generic drugs containing vincamine exist in specific regions.{{clarify|date=June 2016}} Most common drug preparations are in the [[sustained release]] tablet forms.

Vincamine is often used as a [[nootropic]] agent to combat the effects of aging{{clarify|date=March 2017}}, or in conjunction with other nootropics (such as [[piracetam]]) for a variety of purposes.

==See also==
*[[Vinpocetine]]

==References==
{{reflist}}

==External links==
* {{ cite web | url = http://www.mpbio.com/includes/msds/ansi/en/158295-EN-ANSI.pdf | format = pdf | title = Vincamine MSDS }}
* {{ cite web | url = http://ntp-server.niehs.nih.gov/ntp/htdocs/Chem_Background/ExSumPdf/Vincamine.pdf | format = pdf | work = Summary of Data for Chemical Selection | title = Vincamine - 1617-90-9 | author = Chemical Selection Working Group | publisher = NIH - United States National Institutes of Health }}

{{Peripheral vasodilators}}

[[Category:Alcohols]]
[[Category:Carboxylate esters]]
[[Category:Methyl esters]]
[[Category:Nitrogen heterocycles]]
[[Category:Vinca alkaloids]]
[[Category:Heterocyclic compounds (4 or more rings)]]

{{cardiovascular-drug-stub}}